top of page

01

Prurigo Nodularis (PN): Oral 

Prurigo Nodularis phase 2 oral drug with extension study. Enrollment is currently CLOSED.

02

Prurigo Nodularis (PN): Topical 

Prurigo Nodularis Phase 3 topical drug with extension study. Enrollment is currently OPEN.

03

Chronic Spontaneous Urticaria (CSU): 

Chronic Spontaneous Urticaria Phase 3 oral drug with extension study. Enrollment is currently CLOSED.

04

Atopic Dermatitis (Eczema):

​

Atopic Dermatitis Phase 3 oral drug with extension study. Enrollment is currently CLOSED.

CURRENT TRIALS

05

Psoriasis Scalp and Nail (With Taltz):

​

Psoriasis with scalp and nail involvement Phase 4 study with Taltz. Enrollment is currently OPEN.

CLINICAL TRIALS OFFERED

KNOW MORE.
DO MORE.

SERVE MORE.

bottom of page